Sample Answer for NURS 6521 Week 10: Women’s and Men’s Health Included After Question<\/strong><\/em><\/span><\/h2>\nBreast cancer<\/a> is not just a disease that strikes at women. It strikes at the very heart of who we are as women: how others perceive us, how we perceive ourselves, how we live, work, and raise our families\u2014or whether we do these things at all.<\/span>\u00a0<\/span><\/p>\n\u2013Debbie Wasserman Schultz<\/span>\u00a0<\/span><\/p>\nThis sentiment that Schultz expressed is true for many disorders associated with women\u2019s and men\u2019s health such as hormone deficiencies, cancers, and other functional and structural abnormalities. Disorders such as these not only result in physiological consequences but also psychological consequences such as embarrassment, guilt, or profound disappointment for patients. For these reasons, the provider-patient relationship must be carefully managed. During evaluations, patients must feel comfortable answering questions so that you, as a key health-care provider, will be able to diagnose and recommend appropriate treatment options. Advanced practice nurses must be able to educate patients on these disorders and help relieve associated stigmas and concerns.<\/span>\u00a0<\/span><\/p>\nThis week, as you examine women\u2019s and men\u2019s health issues, you focus on treatments for hormone deficiencies and cancer. You also explore preventive services for women\u2019s and men\u2019s health.<\/span>\u00a0<\/span><\/p>\nLearning Objectives<\/span><\/b>\u00a0<\/span><\/h2>\nBy the end of this week, students will:<\/span><\/b>\u00a0<\/span><\/p>\n\n- Evaluate the strengths and limitations of hormone replacement therapy<\/span>\u00a0<\/span><\/li>\n
- Evaluate treatments for hormone deficiencies<\/span>\u00a0<\/span><\/li>\n
- Analyze preventive services for women\u2019s and men\u2019s health<\/span>\u00a0<\/span><\/li>\n
- Analyze drug treatments for cancer patients<\/span>\u00a0<\/span><\/li>\n
- Evaluate implications of cancer drug treatments on patients<\/span>\u00a0<\/span><\/li>\n
- Understand and apply key terms, concepts, and principles related to prescribing drugs to treat disorders associated with women\u2019s and men\u2019s health<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
Photo Credit: Comstock\/Stockbyte\/Getty Images<\/span>\u00a0<\/span><\/p>\n![\"NURS](\"http:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2024\/02\/Capture-2-6-300x103.png\")
NURS 6521 Week 10: Women’s and Men’s Health<\/figcaption><\/figure>\nLearning Resources<\/span><\/b>\u00a0<\/span><\/h2>\nNote:<\/span><\/b> To access this week\u2019s required library resources, please click on the link to the Course Readings List, found in the <\/span>Course Materials<\/span><\/b> section of your Syllabus.<\/span>\u00a0<\/span><\/p>\nThis page contains the Learning Resources for this week. Be sure to scroll down the page to see all of this week’s assigned Learning Resources. To access select media resources, please use the media player below.<\/span>\u00a0<\/span><\/p>\nRequired Readings<\/span><\/b>\u00a0<\/span><\/h2>\nArcangelo, V. P.,\u202fPeterson, A. M., Wilbur, V., & Reinhold, J. A.\u202f(Eds.). (2017). <\/span>Pharmacotherapeutics for advanced practice: A practical approach<\/span><\/i> (4th ed.). Ambler, PA: Lippincott Williams & Wilkins.<\/span>\u00a0<\/span><\/p>\n\n- Chapter 33, \u201cProstatic Disorders and Erectile Dysfunction\u201d (pp. 527-544) <\/span>
\nThis chapter examines the causes, pathophysiology, and drug treatment of four disorders: prostatitis, benign prostatic hyperplasia, prostate cancer, and erectile dysfunction. It also explores the importance of monitoring patient response and patient education.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\u202f<\/span>\u00a0<\/span><\/p>\n\n- Chapter 34, \u201cOveractive Bladder\u201d (pp. 545-564) <\/span>
\nThis chapter describes the causes, pathophysiology, diagnostic criteria, and evaluation of overactive bladder. It also outlines the process of initiating, administering, and managing drug treatment for this disorder.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\u202f<\/span>\u00a0<\/span><\/p>\n\n- Chapter 55, \u201cContraception\u201d (pp. 959-970) <\/span>
\nThis chapter examines various methods of contraception and covers drug interactions, selecting the most appropriate agent, and monitoring patient response to contraceptions.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\u202f<\/span>\u00a0<\/span><\/p>\n\n- Chapter 56, \u201cMenopause\u201d (pp. 971-994) <\/span>
\nThis chapter presents various options for menopausal hormone therapy and examines the strengths and limitations of each form of therapy.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\u202f<\/span>\u00a0<\/span><\/p>\n\n- Chapter 57, \u201cOsteoporosis\u201d (pp. 985-994) <\/span>
\nThis chapter covers various options for treating osteoporosis. It also describes proper dosages, potential adverse reactions, and special considerations of each drug.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\u202f<\/span>\u00a0<\/span><\/p>\n\n- Chapter 58, \u201cVaginitis\u201d (pp. 995-1006) <\/span>
\nThis chapter examines various causes of vaginitis and explores the diagnostic criteria and methods of treatment for the disorder.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\u00a0<\/span><\/p>\nRoberts, H. & Hickey, M. (2016). <\/span>Managing the menopause: An update. Maturitas, 86<\/span><\/i>(2016), 53-58. https:\/\/doi.org\/10.1016\/j.maturitas.2016.01.007 <\/span><\/a>\u00a0<\/span><\/p>\nNote:<\/span><\/b> Retrieved from the Walden Library databases.<\/span><\/a>\u00a0<\/span><\/p>\n\u202f<\/span><\/a>\u00a0<\/span><\/p>\nThis article provides an update on treatments on Vasomotor symptoms (VMS), genito-urinary syndrome of menopause (GSM), sleep disturbance, sexual dysfunction and mood disturbance are common during the menopause transition.<\/span><\/a>\u00a0<\/span><\/p>\n\u00a0<\/span><\/p>\nLunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., & Morgentaler, A. (2015). Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. <\/span>Aging Male<\/span><\/i>, 18(1), 5-15. doi: 10.3109\/13685538.2015.1004049<\/span>\u00a0<\/span><\/p>\nNote:<\/span><\/b> Retrieved from the Walden Library databases.<\/span>\u00a0<\/span><\/p>\nM\u00e4kinen, J. I., & Huhtaniemi, I. (2011). Androgen replacement therapy in late-onset hypogonadism: Current concepts and controversies\u2014A mini-review. <\/span>Gerontology<\/span><\/i>, 57(3), 193\u2013202.<\/span>\u00a0<\/span><\/p>\nNote:<\/span><\/b> Retrieved from the Walden Library databases.<\/span>\u00a0<\/span><\/p>\n\u202f<\/span>\u00a0<\/span><\/p>\nThis article examines the role of testosterone levels in the development of hypogonadism. It also explores health issues that are impacted by testosterone levels and the role of testosterone replacement therapy.<\/span>\u00a0<\/span><\/p>\n\u00a0<\/span><\/p>\nDrugs.com. (2012). Retrieved from http:\/\/www.drugs.com\/<\/span><\/a>\u00a0<\/span><\/p>\n\u202f<\/span><\/a>\u00a0<\/span><\/p>\nThis website presents a comprehensive review of prescription and over-the-counter drugs including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.<\/span><\/a>\u00a0<\/span><\/p>\n\ufffc<\/span>\u00a0<\/span><\/p>\nU.S. Preventive Services Task Force. (2014). <\/span>The Guide to Clinical Preventive Services: Section 2. Recommendations for Adults<\/span><\/i>. Retrieved from http:\/\/www.ahrq.gov\/professionals\/clinicians-providers\/guidelines-recommendations\/guide\/section2.html<\/span><\/a>\u00a0<\/span><\/p>\n
\u2013Debbie Wasserman Schultz<\/span>\u00a0<\/span><\/p>\n This sentiment that Schultz expressed is true for many disorders associated with women\u2019s and men\u2019s health such as hormone deficiencies, cancers, and other functional and structural abnormalities. Disorders such as these not only result in physiological consequences but also psychological consequences such as embarrassment, guilt, or profound disappointment for patients. For these reasons, the provider-patient relationship must be carefully managed. During evaluations, patients must feel comfortable answering questions so that you, as a key health-care provider, will be able to diagnose and recommend appropriate treatment options. Advanced practice nurses must be able to educate patients on these disorders and help relieve associated stigmas and concerns.<\/span>\u00a0<\/span><\/p>\n This week, as you examine women\u2019s and men\u2019s health issues, you focus on treatments for hormone deficiencies and cancer. You also explore preventive services for women\u2019s and men\u2019s health.<\/span>\u00a0<\/span><\/p>\n By the end of this week, students will:<\/span><\/b>\u00a0<\/span><\/p>\n Photo Credit: Comstock\/Stockbyte\/Getty Images<\/span>\u00a0<\/span><\/p>\n Note:<\/span><\/b> To access this week\u2019s required library resources, please click on the link to the Course Readings List, found in the <\/span>Course Materials<\/span><\/b> section of your Syllabus.<\/span>\u00a0<\/span><\/p>\n This page contains the Learning Resources for this week. Be sure to scroll down the page to see all of this week’s assigned Learning Resources. To access select media resources, please use the media player below.<\/span>\u00a0<\/span><\/p>\n Arcangelo, V. P.,\u202fPeterson, A. M., Wilbur, V., & Reinhold, J. A.\u202f(Eds.). (2017). <\/span>Pharmacotherapeutics for advanced practice: A practical approach<\/span><\/i> (4th ed.). Ambler, PA: Lippincott Williams & Wilkins.<\/span>\u00a0<\/span><\/p>\n \u202f<\/span>\u00a0<\/span><\/p>\n \u202f<\/span>\u00a0<\/span><\/p>\n \u202f<\/span>\u00a0<\/span><\/p>\n \u202f<\/span>\u00a0<\/span><\/p>\n \u202f<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Roberts, H. & Hickey, M. (2016). <\/span>Managing the menopause: An update. Maturitas, 86<\/span><\/i>(2016), 53-58. https:\/\/doi.org\/10.1016\/j.maturitas.2016.01.007 <\/span><\/a>\u00a0<\/span><\/p>\n Note:<\/span><\/b> Retrieved from the Walden Library databases.<\/span><\/a>\u00a0<\/span><\/p>\n \u202f<\/span><\/a>\u00a0<\/span><\/p>\n This article provides an update on treatments on Vasomotor symptoms (VMS), genito-urinary syndrome of menopause (GSM), sleep disturbance, sexual dysfunction and mood disturbance are common during the menopause transition.<\/span><\/a>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Lunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., & Morgentaler, A. (2015). Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. <\/span>Aging Male<\/span><\/i>, 18(1), 5-15. doi: 10.3109\/13685538.2015.1004049<\/span>\u00a0<\/span><\/p>\n Note:<\/span><\/b> Retrieved from the Walden Library databases.<\/span>\u00a0<\/span><\/p>\n M\u00e4kinen, J. I., & Huhtaniemi, I. (2011). Androgen replacement therapy in late-onset hypogonadism: Current concepts and controversies\u2014A mini-review. <\/span>Gerontology<\/span><\/i>, 57(3), 193\u2013202.<\/span>\u00a0<\/span><\/p>\n Note:<\/span><\/b> Retrieved from the Walden Library databases.<\/span>\u00a0<\/span><\/p>\n \u202f<\/span>\u00a0<\/span><\/p>\n This article examines the role of testosterone levels in the development of hypogonadism. It also explores health issues that are impacted by testosterone levels and the role of testosterone replacement therapy.<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Drugs.com. (2012). Retrieved from http:\/\/www.drugs.com\/<\/span><\/a>\u00a0<\/span><\/p>\n \u202f<\/span><\/a>\u00a0<\/span><\/p>\n This website presents a comprehensive review of prescription and over-the-counter drugs including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.<\/span><\/a>\u00a0<\/span><\/p>\n \ufffc<\/span>\u00a0<\/span><\/p>\n U.S. Preventive Services Task Force. (2014). <\/span>The Guide to Clinical Preventive Services: Section 2. Recommendations for Adults<\/span><\/i>. Retrieved from http:\/\/www.ahrq.gov\/professionals\/clinicians-providers\/guidelines-recommendations\/guide\/section2.html<\/span><\/a>\u00a0<\/span><\/p>\nLearning Objectives<\/span><\/b>\u00a0<\/span><\/h2>\n
\n
Learning Resources<\/span><\/b>\u00a0<\/span><\/h2>\n
Required Readings<\/span><\/b>\u00a0<\/span><\/h2>\n
\n
\nThis chapter examines the causes, pathophysiology, and drug treatment of four disorders: prostatitis, benign prostatic hyperplasia, prostate cancer, and erectile dysfunction. It also explores the importance of monitoring patient response and patient education.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\n
\nThis chapter describes the causes, pathophysiology, diagnostic criteria, and evaluation of overactive bladder. It also outlines the process of initiating, administering, and managing drug treatment for this disorder.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\n
\nThis chapter examines various methods of contraception and covers drug interactions, selecting the most appropriate agent, and monitoring patient response to contraceptions.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\n
\nThis chapter presents various options for menopausal hormone therapy and examines the strengths and limitations of each form of therapy.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\n
\nThis chapter covers various options for treating osteoporosis. It also describes proper dosages, potential adverse reactions, and special considerations of each drug.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n\n
\nThis chapter examines various causes of vaginitis and explores the diagnostic criteria and methods of treatment for the disorder.\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n